Pharmacokinetic study of sulpiride in humans using [C-11]sulpiride

Pharmacokinetic study of sulpiride in humans using [C-11]sulpiride - Pharmacokinetics of [C-11]sulpiride

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000004570

Enrollment

Registered

2010-11-16

Start date

2010-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy male subjects

Interventions

Intravenous injection of [C-11]sulpiride for PET-CT imaging in baseline and after oral administration of a therapeutic dose of sulpiride.

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Healthy male subjects who have the ability to provide informed consent

Exclusion criteria

Exclusion criteria: -Psychiatric disorders including drug dependence -Serious medical illness

Design outcomes

Primary

Measure	Time frame
Pharmacokinetics of [C-11]sulpiride and its changes after oral administration of sulpiride in a therapeutic dose	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026